The Role of Epidermal Growth Factor Receptor in Diabetes-Induced Cardiac Dysfunction

被引：35
|
作者：
Akhtar, Saghir [1 ]
Benter, Ibrahim Fadil [1 ]
机构：
[1] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait
来源：
BIOIMPACTS | 2013年 / 3卷 / 01期
关键词：
Cardiac Dysfunction; EGF; EGFR; RAAS; erbB; Diabetes; Heart Ischemia-Reperfusion Injury;
D O I：
10.5681/bi.2013.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The incidence of diabetes mellitus is increasing rapidly and set to reach near epidemic proportions with the latest estimates suggesting that by 2030 there will be over 550 million people with this debilitating disease. Cardiovascular complications and dysfunctions are three-to eight-folds more likely in diabetic patients and are major causes of increased mortality. The exact underlying mechanisms for the development of complications of the diabetic heart are poorly understood and may involve multiple signaling pathways that are affected by hyperglycemia. This focused article reviews the recent evidence for a possible dual role of epidermal growth factor receptor signaling in diabetes-induced cardiac dysfunction.
引用
收藏
页码：5 / 9
页数：5
相关论文
共 50 条
  • [21] Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis
    Mohanraj Rajesh
    Partha Mukhopadhyay
    Sándor Bátkai
    Muhammad Arif
    Zoltán V. Varga
    Csaba Mátyás
    Janos Paloczi
    Andrea Lehocki
    György Haskó
    Pal Pacher
    GeroScience, 2022, 44 : 1727 - 1741
  • [22] Leukocytic toll-like receptor 2 knockout protects against diabetes-induced cardiac dysfunction
    Lei, Lei
    Hu, Houxiang
    Lei, Yan
    Feng, Jie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 506 (03) : 668 - 673
  • [23] Diabetes and microvascular pathophysiology: role of epidermal growth factor receptor tyrosine kinase
    Matrougui, Khalid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (01) : 13 - 16
  • [24] The pivotal role of nuclear factor erythroid 2-related factor 2 in diabetes-induced endothelial dysfunction
    Karan, Amin
    Bhakkiyalakshmi, Elango
    Jayasuriya, Ravichandran
    Sarada, D. V. L.
    Ramkumar, Kunka Mohanram
    PHARMACOLOGICAL RESEARCH, 2020, 153
  • [25] Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis
    Wang, Wen-Ke
    Lu, Qing-Hua
    Wang, Xin
    Wang, Ben
    Wang, Juan
    Gong, Hui-Ping
    Wang, Lin
    Li, Hao
    Du, Yi-Meng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 2497 - 2504
  • [26] IRAP - A novel target to combat diabetes-induced cardiac and vascular dysfunction
    Hollands, Cameron
    Ferens, Dorota
    Salimova, Ekaterina
    Spizzo, Iresha
    Chai, Siew
    Widdop, Robert
    Gaspari, Tracey
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 142 - 142
  • [27] DIABETES-INDUCED CARDIAC CHANGES
    MCNEILL, JH
    TAHILIANI, AG
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (09) : 364 - 367
  • [28] EPIDERMAL GROWTH FACTOR-INDUCED TRUNCATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR
    DECKER, SJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (30) : 17641 - 17644
  • [29] Epidermal Growth Factor Receptor Mediates the Vascular Dysfunction But Not the Remodeling Induced by Aldosterone/Salt
    Griol-Charhbili, Violaine
    Fassot, Celine
    Messaoudi, Smail
    Perret, Claudine
    Agrapart, Vincent
    Jaisser, Frederic
    HYPERTENSION, 2011, 57 (02) : 238 - 244
  • [30] The Epidermal Growth Factor Receptor Mediates the Vascular Dysfunction but not the Remodeling Induced by Aldosterone/Salt
    Jaisser, Frederic
    Chahrbili, Violaine
    Fassot, Celine
    Messaoudi, Smail
    HYPERTENSION, 2010, 56 (05) : E73 - E73
12345